The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

This review will focus on the development of vaccines against influenza A/H5N1 strains. Reducing the impact of the potential pandemic would entail pharmaceutical and nonpharmaceutical interventions.

If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...

Following a prolonged but ultimately successful application process, South Africa’s largest poultry company has become the ...

San Francisco, USA-based biotech Centivax, which is developing durable, universal vaccines, today announced the close of a ...

During his Senate confirmation hearings, Health Secretary Robert F. Kennedy Jr. suggested he wouldn’t undermine vaccines. “I ...

The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.

Iowa Secretary of Ag Weighs In on The H5N1 Battle, Vaccine Potential And Trade Sensitivities Sec. Mike Naig says the U.S. government is using what he describes as a three-legged stool approach to ...

Cambodia's health ministry today announced another human H5N1 avian flu case of the year, involving a 5-year-old boy from ...

Arboviruses are spreading beyond tropical and subtropical regions due to climate change, population growth, and increased ...

Vaccine fate. The Zoetis H5N1 vaccine approved in 2016 remained in the National Veterinary Stockpile until 2021 but was never used.